Duato Joaquin Form 3 JOHNSON & JOHNSON / Joaquin Duato ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Duato Joaquin

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2016

3. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Exec VP, WW Chair, Pharma

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	47,960	D
Common Stock	538(1)	I	By 401k

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)(2)	02/10/2012	02/08/2019	Common Stock	34,288	58.33	D
Employee Stock Options (Right to Buy)(2)	02/12/2011	02/10/2018	Common Stock	20,842	61.75	D
Employee Stock Options (Right to Buy)(2)	01/11/2014	01/08/2021	Common Stock	19,293	62.2	D
Employee Stock Options (Right to Buy)(2)	01/18/2015	01/17/2022	Common Stock	100,000	65.37	D
Employee Stock Options (Right to Buy)(2)	01/17/2016	01/13/2023	Common Stock	148,538	72.54	D
Employee Stock Options (Right to Buy)(2)	02/11/2017	02/09/2024	Common Stock	130,969	90.44	D
Employee Stock Options (Right to Buy)(2)	02/10/2018	02/09/2025	Common Stock	126,369	100.06	D
Employee Stock Options (Right to Buy)(2)	02/09/2019	02/08/2026	Common Stock	125,824	101.87	D
Restricted Share Units(3)	02/08/2019	(3)	Common Stock	9,049	(3)	D
Restricted Share Units(3)	02/09/2018	(3)	Common Stock	9,812	(3)	D
Restricted Share Units(3)	02/10/2017	(3)	Common Stock	8,919	(3)	D

Explanation of Responses:

1. Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan.

2. Vested and exercisable one day after the third anniversary of the date of the grant.

3. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:

duatopoa.txt

	Linda E. King, as attorney-in-fact for Joaquin Duato	05/05/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.